MedPath

Gait modifications of type 2 diabetes neuropathy patients following task-oriented motor sequence gait trainings

Not Applicable
Conditions
Gait training in type 2 diabetes neuropathy
Registration Number
JPRN-UMIN000018951
Lead Sponsor
Hoda Salsabili
Brief Summary

Gait trainings showed statistically significant increase in second vertical peak force and Propulsive Force despite decrease in the vertical minimum force and breaking force (P>0.05). However, just second vertical peak force, vertical minimum force and propulsive showed significant differences in the pairwise comparisons (P>0.05). There was no significant differences in the first vertical peak force, breaking time and propulsive time after trainings (P<0.05). TGUG significantly decreased while FES-I reflected significantly increase after gait trainings (P>0.05).

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
15
Inclusion Criteria

Not provided

Exclusion Criteria

Patients were excluded from this study if they had retinopathy, scares under their feet, hypo or hypertension, autonomic neuropathy or any orthopedic and neurologic disorder that influence walking performance in patients. Also, patients had no experience with similar gait trainings or balance practices.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Gait trainings showed statistically significant increase in second vertical peak force and Propulsive Force despite decrease in the vertical minimum force and breaking force (P>0.05). However, just second vertical peak force, vertical minimum force and propulsive showed significant differences in the pairwise comparisons (P>0.05). There was no significant differences in the first vertical peak force, breaking time and propulsive time after training (P<0.05). Time Get Up and Go significantly decreased while Fall Efficacy Scale-Iinternational reflected significantly increase after gait trainings (P>0.05).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath